| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/29/2004 | EP1209967A4 Exogenic allelism |
| 12/29/2004 | EP1196616B1 Replication-competent anti-cancer vectors |
| 12/29/2004 | EP1196581B1 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained |
| 12/29/2004 | EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases |
| 12/29/2004 | EP1151138B1 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
| 12/29/2004 | EP1146959A4 Method and apparatus for liposome production |
| 12/29/2004 | EP1146909A4 Method of treating cancer by restoration of pp32 function |
| 12/29/2004 | EP1123509B1 Methods of diagnosing or prognosing alzheimer's disease |
| 12/29/2004 | EP1117808B1 Transformation system in the field of filamentous fungal hosts: in chrysosporium |
| 12/29/2004 | EP1112367B1 Agents and methods for modifying the glutamine metabolism in plants, especially in sugar beet |
| 12/29/2004 | EP1090033B1 Particles of hcv envelope proteins: use for vaccination |
| 12/29/2004 | EP1084251B1 Attenuated pestiviruses |
| 12/29/2004 | EP1071768B1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum |
| 12/29/2004 | EP1066375B1 $i(LACTOBACILLI) HARBORING AGGREGATION AND MUCIN BINDING GENES AS VACCINE DELIVERY VEHICLES |
| 12/29/2004 | EP1064393B1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 12/29/2004 | EP1012334A4 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 12/29/2004 | EP0996709B1 Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes |
| 12/29/2004 | EP0979308B1 Method of preparing a standard diagnostic gene transcript pattern |
| 12/29/2004 | EP0954527B1 Glycine transporter-transfected cells and uses thereof |
| 12/29/2004 | EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY |
| 12/29/2004 | EP0920632B1 Methods for detection of autoimmune diseases |
| 12/29/2004 | EP0868431B1 Protein with plant protecting properties |
| 12/29/2004 | EP0836649B1 Cell-free synthesis of polyketides |
| 12/29/2004 | EP0830130B9 Tnf-alpha converting enzyme |
| 12/29/2004 | EP0785946B1 Materials for the production of nanometer structures and use thereof |
| 12/29/2004 | EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS |
| 12/29/2004 | EP0722342B1 REGULATION OF bcl-2 GENE EXPRESSION |
| 12/29/2004 | EP0653940B1 Glial mitogenic factors, their preparation and use |
| 12/29/2004 | EP0626008B1 Vaccine containing acemannan as an adjuvant |
| 12/29/2004 | EP0623172B1 Marek's disease virus recombinant vaccinia virus vaccine |
| 12/29/2004 | CN1559047A DNA providing system |
| 12/29/2004 | CN1558957A Detection method of nucleic acid hybridization |
| 12/29/2004 | CN1558955A Method and system detecting inter-chromosomal imbalance by fluorescent in situ hybridization on interphase nuclei |
| 12/29/2004 | CN1558954A Genotyping kit for diagnosis of human papilloma virus infection |
| 12/29/2004 | CN1558953A Biosynthetic genes of blakeslea trispora beta-carotene that code for lycopene cyclase/phytoene synthase (carRP) and phytoene dehydrogenase (carB) |
| 12/29/2004 | CN1558952A Pegylated and diglycosylated erythropoietin |
| 12/29/2004 | CN1558951A Nucleic acid extraction device |
| 12/29/2004 | CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell |
| 12/29/2004 | CN1558949A Preparing somatic embryo by utilizing rabbit oocyte |
| 12/29/2004 | CN1558947A Peptide synthase gene, peptide synthase and process for producing dipdptide |
| 12/29/2004 | CN1558916A Compositions and methods for generating chimeric heteromultimers |
| 12/29/2004 | CN1558914A Receptor, the use thereof, and mouse antibodies |
| 12/29/2004 | CN1558913A Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, RNA processing and/or translation |
| 12/29/2004 | CN1558912A Method for making acylated polypeptides |
| 12/29/2004 | CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 12/29/2004 | CN1558774A Angiotensin peptide-carrier conjugates and uses thereof |
| 12/29/2004 | CN1558207A Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 12/29/2004 | CN1557960A Method for separating antibiotic peptide and separated antibiotic peptide |
| 12/29/2004 | CN1557954A Expression and application of transduction peptides - human insulinogen fusion protein |
| 12/29/2004 | CN1557953A Encoding sequence of anti-drought salt-resistant cold-tolerant kale protein BoRSl |
| 12/29/2004 | CN1557952A Solanum lycopersicoides dun. S1Ve1 receptor protein encoding sequence and use thereof |
| 12/29/2004 | CN1557951A Method for preparing non-receptor type tyrosine protein kinase Syk and use thereof |
| 12/29/2004 | CN1557949A Novel cholesterol oxidase gene and use thereof |
| 12/29/2004 | CN1557835A Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same |
| 12/29/2004 | CN1182247C Sequence-specific DNA recombination in eukaryotic cells |
| 12/29/2004 | CN1182246C Mutant ilvH gene and process for producing L-valine |
| 12/29/2004 | CN1182245C Gene associated with brachydactyly and body height |
| 12/29/2004 | CN1182244C Method of cell cultivation |
| 12/29/2004 | CN1182242C Ecological safety type nitragin preparation production process and its production method |
| 12/29/2004 | CN1182240C Barm expressing system of plasminogen and purifying process |
| 12/29/2004 | CN1182238C Aspergillus tamarii var.Yunnanensis Ym3221 |
| 12/29/2004 | CN1182155C Recombinant human hepatocyte auxin, its preparing process and its clinical application |
| 12/29/2004 | CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine |
| 12/29/2004 | CN1181887C Recombinant gamma-interferon for preventing and treating cow's recessive mammitis |
| 12/29/2004 | CN1181885C Administration of polypeptide growth factors after central nervous system ischemia or trauma |
| 12/29/2004 | CA2570502A1 Castanea sativa mill. genes codifying for allene oxide cyclase, cystatin, beta-1,3-glucanase and thaumatin-like protein and their use |
| 12/29/2004 | CA2535660A1 Method of improving fertility of hybrid plant comprising locating fertility restoration genes on plural loci |
| 12/29/2004 | CA2530049A1 Methods and means for delaying seed shattering in plants |
| 12/29/2004 | CA2529838A1 Isoforms of eif-5a: senescence-induced eif5a; wounding-induced eif-5a; growth eif-5a; and dhs |
| 12/29/2004 | CA2529659A1 Engineered proteolytic enzyme with altered specificity determining regions |
| 12/29/2004 | CA2529587A1 Plant transcriptional activator and uses thereof |
| 12/29/2004 | CA2529565A1 Modified bordetella adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof |
| 12/29/2004 | CA2529520A1 Interleukin-21 analogs |
| 12/29/2004 | CA2529455A1 Plant limit dextrinase inhibitor |
| 12/29/2004 | CA2529142A1 Rna interferases and methods of use thereof |
| 12/29/2004 | CA2529129A1 Limit dextrinase inhibitor promoter |
| 12/29/2004 | CA2528845A1 Modified oleosins |
| 12/29/2004 | CA2528599A1 Proton-sensing g-protein coupled receptors and dna sequences thereof |
| 12/29/2004 | CA2528529A1 Gene amplification and overexpression in cancer |
| 12/29/2004 | CA2528002A1 Improved method for the recovery of non-segmented, negative-stranded rna viruses from cdna |
| 12/29/2004 | CA2526648A1 Method for producing a synthetic gene or other dna sequence |
| 12/29/2004 | CA2526647A1 Anti alpha - folate - receptor - tetramer antibodies |
| 12/29/2004 | CA2526640A1 Immunogenic reagents from west nile virus |
| 12/29/2004 | CA2525953A1 High titer recombinant influenza viruses for vaccines and gene therapy |
| 12/29/2004 | CA2525379A1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 12/28/2004 | US6835946 Image reading method and apparatus |
| 12/28/2004 | US6835868 For agriculture/horticulture; improved yield; genetic engineering |
| 12/28/2004 | US6835867 For genetic mapping; in vitro stem cell cultures |
| 12/28/2004 | US6835866 Compositions and methods of modulating cholesterol metabolism |
| 12/28/2004 | US6835826 Acid resistance, stability; telomerase inhibitor |
| 12/28/2004 | US6835825 For regulating activation/development/differentiation of hematopoietic cells |
| 12/28/2004 | US6835821 Useful mutations of bacterial alkaline protease |
| 12/28/2004 | US6835820 Polyhydroxyalkanoate biosynthesis associated proteins and coding region in bacillus megaterium |
| 12/28/2004 | US6835818 Mutants of Streptococcal toxin C and methods of use |
| 12/28/2004 | US6835817 Monoclonal antibody which is specific for activated coagulation factor VII, and its use |
| 12/28/2004 | US6835816 Mammalian tumor susceptibility genes and their uses |
| 12/28/2004 | US6835815 Nod2 nucleic acids and proteins |
| 12/28/2004 | US6835813 Testis-specific differentiation-regulatory factor |
| 12/28/2004 | US6835810 Fusion protein for use as vector |
| 12/28/2004 | US6835809 Thrombopoietic compounds |